William Harter, MD, is vice chair of the Department of Radiation Medicine at MedStar Georgetown University Hospital and the Lombardi Comprehensive Cancer Center, and co-director of their multidisciplinary Head and Neck Cancer/Skull-Base Tumor Service. He also holds the rank of professor at Georgetown University Medical School.
Board-certified in Radiation Oncology, Dr. Harter was a clinical fellow in head and neck radiation oncology at Massachusetts General Hospital/Harvard Medical School in 1982. Previously, he was a resident at the Harvard Joint Center for Radiation Therapy, preceded by a residency in radiation oncology and an internship in general surgery, both at the Mayo Clinic. Dr. Harter received his medical degree from the Louisiana State University School of Medicine in 1978.
Dr. Harter's work has been published in many scientific journals and periodicals, and he has written numerous chapters for medical textbooks. He has been recognized as a "Top Doctor" by Washingtonian magazine every year since the award's inception.
Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, del Carmen Viroglio C, Venkatesan V, Romanov I, Agarwala S, HARTER KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM, Haddad RI. Cisplatin And Fluorouracil Alone Or With Docetaxel In Head And Neck Cancer, N Engl J Med, 357(17):1705-1715. October 2007.
Kress MA, Sen N, Unger KR, Lominska CE, Deeken JF, Davidson BJ, Newkirk KA, Hwang J, HARTER KW. Hypofractionated Stereotactic Body Re-Irradiation In Head And Neck Cancer: Long-Term Follow-Up Of A Large Series Demonstrates Safety And Efficacy, Head Neck. May 2014.
Unger KR, Howard M, Slack R, Hartmann D, Newkirk K, Davidson B, Berkowitz F, Steadman K, Deeken J, HARTER KW. HPV-Positive Status Predicts For Improved Outcomes In Head And Neck Squamous Cell Carcinoma After Concurrent Cetuximab And Radiation Therapy, Int J Radiat Oncol Biol Phys, 78(3):S458. November 2010.
Unger KR, Lominska CE, Deeken JF, Davidson BJ, Newkirk KA, Gagnon GJ, Hwang J, Slack RS, Noone AM, HARTER KW. Fractionated Stereotactic Radiosurgery For Reirradiation Of Head-And-Neck Cancer, Int J Radiat Oncol Biol Phys, 77(5):1411-1419. August 2010.
Deeken JF, Newkirk K, HARTER KW, Marshall MB, Banovac F, Johnson L, Wang H, Wang Y, Zhuang T, Jay AK, Berkowitz F, Esposito G, Kallakury B, Davidson B. Effect Of Multimodality Treatment On Overall Survival For Patients With Metastatic Or Recurrent HPV-Positive Head And Neck Squamous Cell Carcinoma. Head Neck. February 2014.
Karam I, Yao M, Heron DE, Poon I, Koyfman S, Yom SS, Siddiqui F, Lartigau E, Cengiz M, Yamazaki H, Hara W, Phan J, Vargo J, Lee VH, Foote RL, HARTER KW, Lee NY, Sahgal A, Lo SS. Consensus Statement from the International Stereotactic Body Radiotherapy Consortium for Head and Neck Carcinoma – Patient Selection and Pre and Post Stereotactic Body Radiation Therapy Evaluation. Int J of Radiation Oncology Biol Phys. October 1, 2016. 96 (25): E364-E365.
Karam I, Yao M, Heron DE, Poon I, Koyfman S, Yom SS, Siddiqui F, Lartigau E, Cenigiz M, Yamazaki H, Hara W, Phan J, Vargo J, Lee VH, Foote RL, HARTER KW, Lee NY, Sahgal A, Lo SS. Consensus Statement from the International Stereotactic Body Radiotherapy Consortium for Head and Neck Carcinoma – Technical Factors. Int J of Radiation Oncology Biol Phys. October 1, 2016. 96 (25): E382-E383.
Karam SD, Snider JW, Wang H, Wooster M, Lominska C, Deeken JF, Newkirk K, Davidson B, HARTER KW. Reirradiation Of Recurrent Salivary Gland Malignancies With Fractionated Stereotactic Body Radiation Therapy, J Radiat Oncol, 1(2):147–153. June 2012.
Karam SD, Rashid A, Snider JW, Wooster M, Bhatia S, Jay AK, Newkirk KA, Davidson B, HARTER KW. IMRT with Stereotactic Body Radiotherapy Boost for High Risk Malignant Salivary Gland Malignancies: A Case Series, Front Oncol, July 2014.
Karam SD, Snider JW, Wang H, Wooster M, Lominska C, Deeken J, Newkirk K, Davidson B, HARTER KW. Survival Outcomes Of Patients Treated With Hypofractionated Stereotactic Body Radiation Therapy For Parotid Gland Tumors: A Retrospective Analysis, Front Oncol, 2:55. May 2012.
Washingtonian "Top Doctors"